Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer: Abstracted from: Douillard J, Hoff P, Skillings J et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2002; 20: 3605–16.

✍ Scribed by Borut Stabuc

• Book ID: 117487680
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 82 KB
• Volume: 29
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/s0305-7372(02)00125-1